This Methylcobalamin 1 mg/ml to 20 mg/ml Injection Solution is a compounded formulation designed for the treatment of various conditions including neuropathy, anemia, B12 deficiency, megaloblastic anemia, and Leber's disease
## **Other similar codes** - J1815 - Injection, insulin, per 5 units - J1817 - Insulin for administration through dme (i.e., insulin pump) per 50 units - J3310 - Injection, perphenazine, up to 5 mg - J0586 - Injection, abobotulinumtoxina, 5 units - J2357 - Injection, omalizumab, 5 mg Frequently asked questions
Although cyanocobalamin is more readily absorbed, much of it is excreted through the urine before it can reach the cells Cyanocobalamin vs Hydroxocobalamin In comparison to hydroxocobalamin, cyanocobalamin has a significantly worse absorption rate and storability, which is why today mostly hydroxocobalamin is used in B12 injections
PubChem Reference: View compound profile on NIH PubChem This product is strictly for research purposes only
Interactions between host PPARs and gut microbiota in health and disease
